March 27 (Reuters) - Drug developer Codiak BioSciences Inc said on Monday it has filed for Chapter 11 bankruptcy protection and will seek to sell its assets, months after the company reduced its workforce by 37%.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shounak Dasgupta)
((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.